Pfizer Inc. logo

Pfizer Inc.

PFE
HealthcareNYSEUnited States
26.89USD+0.12 (+0.45%)

About Pfizer

Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, markets, distributes, sells a wide range of medicines and vaccines.

The company operates in several therapeutic areas, including cardiovascular metabolic, women's health, oncology, anti-infectives, and immunology.

Key Products & Brands:

  • Cardiovascular Metabolic and Women's Health: Premarin family, Eliquis

  • Immunotherapies: Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, Braftovi

  • Sterile Injectables and Anti-Infectives: Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, Paxlovid

  • Vaccines: Comirnaty (COVID-19), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, Prevnar family

  • Biosimilars for Chronic Immune and Inflammatory Diseases: Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, Cibinqo

  • Amyloidosis, Hemophilia and Endocrine Diseases: Vyndaqel/Vyndamax, BeneFIX and Genotropin brands.

Pfizer serves a diverse customer base, including wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual healthcare provider offices. The company also supports disease control and prevention centers.

Pfizer has several collaboration agreements with leading pharmaceutical and biotech companies such as Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc., Merck KGaA, Valneva SE, BioNTech SE, and Arvinas, Inc.

Pfizer continues to leverage its expertise in biopharmaceuticals to address some of the world's most pressing health challenges through innovation and collaboration.

Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer's Business Strategy

Pfizer's core strategy revolves around discovering, developing, manufacturing, and marketing innovative medicines and vaccines aimed at delivering "Breakthroughs that change patients' lives." The company focuses its R&D efforts and commercial activities on key therapeutic areas, including Oncology (significantly bolstered by the recent acquisition of Seagen),…

Available on Finplify

Free account required

Sign up free

Our Take on Pfizer

Pros:

Global Biopharma Giant: Pfizer is one of the world’s largest biopharma companies, with a portfolio spanning vaccines, oncology, inflammation, rare diseases, and internal medicine. Its global footprint and therapeutic diversification support steady revenue generation.

Cash Position from COVID Success: The success of Pfizer’s…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla
Employees
81,000
IPO Date
1972-06-01
ISIN
US7170811035
Website
pfizer.com

Key Metrics

Market Cap
152.90BUSD
P/E Ratio (TTM)
19.59
Net Profit Margin
12.42%
Debt / Asset Ratio
0.32
Dividend Yield (TTM)
6.42%
Volume
5.61M
Avg Volume
57.10M
Shares Outstanding
5.69B
Free Float
99.91%
β Beta
0.44
52W Range
20.9 - 27.9

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
3.1/5Average
Liquidity
2.2/5Weak
Leverage
4.0/5Good
Cash Flow
5.0/5Excellent
Valuation
4.0/5Good

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Pfizer

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.